ISBA vs MRNA · P/E 15, rev $51.3M vs rev $145.0M
Isabella Bank Corporation (ISBA) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Isabella Bank Corporation (ISBA) is a banks - regional company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported ISBA revenue for 2026-06-30 was $51.3M. Net income was $10.0M. ISBA currently screens at market cap $211.1M and trailing P/E 14.5.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
ISBA currently screens at market cap $211.1M and trailing P/E 14.5. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the ISBA and MRNA stock pages for the full models.
Not investment advice.